NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 129 filers reported holding NURIX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 19,244 | $151,258 | 0.00% |
LAZARD ASSET MANAGEMENT LLC | 5,674 | $44 | 0.00% |
Legal & General Group Plc | 31,979 | $251,356 | 0.00% |
Mirae Asset Global Investments Co., Ltd. | 27,375 | $215,168 | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 26,275 | $206,522 | 0.00% |
D. E. Shaw & Co., Inc. | 25,358 | $199,314 | 0.00% |
TWO SIGMA ADVISERS, LP | 19,200 | $150,912 | 0.00% |
JANUS HENDERSON GROUP PLC | 12,933 | $101,717 | 0.00% |
NATIXIS | 5,760 | $45,274 | 0.00% |
WELLS FARGO & COMPANY/MN | 34,046 | $267,601 | 0.00% |
Daiwa Securities Group Inc. | 152 | $1 | 0.00% |
External links
This page lists NURIX THERAPEUTICS INC's shareholders in Q3 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.